G. Alfthan et al., RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY, Atherosclerosis, 106(1), 1994, pp. 9-19
The relation of serum total homocysteine and lipoprotein(a) (Lp(a)) wi
th the incidence of atherosclerotic disease was investigated among 742
4 men and women aged. 40-64 years free of atherosclerotic disease at b
aseline in 1977. During the 9-year follow-up, 134 male and 131 female
cases with either myocardial infarction or stroke were identified. For
each case a control subject was selected belonging to the same sex an
d 5-year age group. Serum samples collected in 1977 were stored at -20
degrees C and analyzed in 1991. The mean serum homocysteine concentra
tion of male cases and controls was 9.99 mu mol/l and 9.82 mu mol/l at
baseline and that of female cases and controls 9.58 mu mol/l and 9.24
mu mol/l, respectively. The median serum Lp(a) concentration of male
cases and controls was 73 mg/l and 108 mg/l and that of female cases a
nd controls 113 mg/l and 91 mg/l, respectively. The differences betwee
n cases and controls were not statistically significant. There was als
o no significant association between either homocysteine or Lp(a) and
atherosclerotic disease, myocardial infarction or stroke in logistic r
egression analyses. The odds ratios varied from 1.00 to 1.26 for homoc
ysteine and from 0.81 to 1.06 for Lp(a). The results of this prospecti
ve population-based study do not support the hypotheses that serum hom
ocysteine or Lp(a) are risk factors for atherosclerotic disease. The l
ack of association between serum homocysteine and atherosclerotic dise
ase may be due to the exceptionally low gene frequency predisposing to
homocysteinemia in Finland.